Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients.

Marina Talamonti Marco GalluzzoJ M van den ReekE M de JongJ L W LambertP MalagoliL BianchiA Costanzo

Published in: The British journal of dermatology (2017)

The results from our new, large cohort of European patients treated with ustekinumab in daily clinical practice confirm the role of HLA-C*06 as a potential predictor of response to ustekinumab.

Keyphrases

clinical practice
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
physical activity
patient reported outcomes
climate change
human health